| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/06/2006 | US20060075512 Transgenic mice containing PAFR gene disruptions |
| 04/06/2006 | US20060075511 Muir-Torre-like syndrome in Fhit deficient mice |
| 04/06/2006 | US20060074824 Prediction by collective likelihood from emerging patterns |
| 04/06/2006 | US20060074234 Isolated mammalian membrane protein genes; related reagents |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074229 Monoclonal antibodies induce apoptosis |
| 04/06/2006 | US20060074227 Antibodies against PRO Polypeptides which may be overexpressed in tumors |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060074045 Vector for transfection of eukaryotic cells |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074043 Antisense modulation of matrix metalloproteinase 1 expression |
| 04/06/2006 | US20060074041 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 04/06/2006 | US20060074039 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 04/06/2006 | US20060074038 Her-2 neu dna vaccine having anti-cancer activity |
| 04/06/2006 | US20060074037 Producing/evaluating a protein/polypeptide (alpha-defensin) with increased antimicrobial activity and stability to effect chemotaxis of T-cells, neutrophil recruitment, or cytokine or interleukin-8 release; immunostimulants; respiratory system disorders; inflammatory bowel disease; viricides; cancer; HIV |
| 04/06/2006 | US20060074022 Prevention of primary Sjogren's Syndrome by ICA69 deficiency |
| 04/06/2006 | US20060074007 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
| 04/06/2006 | US20060073611 Immunoassay |
| 04/06/2006 | US20060073597 Highly controllable electroporation and applications thereof |
| 04/06/2006 | US20060073596 Oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers; non-toxic and effective in low doses |
| 04/06/2006 | US20060073595 Recombinant Adenoviruses which function as helper viruses to gutted Ad viruses lacking viral coding sequences; gene therapy |
| 04/06/2006 | US20060073594 Chimeric vectors |
| 04/06/2006 | US20060073593 Compositions and methods for molecular biology |
| 04/06/2006 | US20060073586 A N-terminal domain, five or six rod repeats, H1 and H4 domains of a dystrophin protein, and a cysteine-rich domain; Duchenne and Becker muscular dystrophies |
| 04/06/2006 | US20060073583 food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity |
| 04/06/2006 | US20060073580 Glucose dehydrogenase |
| 04/06/2006 | US20060073575 Methods and reagents for assaying protein kinase activity |
| 04/06/2006 | US20060073574 Engineered biosynthesis of novel polyenes |
| 04/06/2006 | US20060073573 Chemotactic cytokine III |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073568 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073566 Active modified hedgehog proteins |
| 04/06/2006 | US20060073565 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 04/06/2006 | US20060073564 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) |
| 04/06/2006 | US20060073562 Screening and identifying compounds compounds that will modulate the interaction of protein tyrosine kinase substrates with their intracellular ligands, as well as between their intracellular ligands and other members of the signaling pathway. |
| 04/06/2006 | US20060073560 Selective expression in filamentous fungi |
| 04/06/2006 | US20060073559 Ehanced protein expression in bacillus |
| 04/06/2006 | US20060073546 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073545 PRO polypeptides and chimeric polypeptides; may be drug target for tumors |
| 04/06/2006 | US20060073544 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060073542 Catalyze transfer of a fucose residue from a donor to an acceptor substrate in enzymatic synthesis of oligosaccharide moieties of glycoproteins and glycolipids |
| 04/06/2006 | US20060073515 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
| 04/06/2006 | US20060073507 Orthogonal pairs of tRNAs and aminoacyl-tRNA synthetases incorporate para-propargyloxyphenylalanine into proteins produced in E. coli |
| 04/06/2006 | US20060073498 GlcNAc phosphotransferase of the lysosomal targeting pathway |
| 04/06/2006 | US20060073485 Sequencing preferential nucleotide sequences; obtain oligomer, label, digest, separate, perform mass spectrum analysis, determine sequence |
| 04/06/2006 | US20060073482 Analysis of biological samples |
| 04/06/2006 | US20060073481 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 04/06/2006 | US20060073479 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
| 04/06/2006 | US20060073478 Atlastin |
| 04/06/2006 | US20060073468 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073168 contacting an isolated serogroup A meningococcal capsular polysaccharide with an isolated Serogroup A Neisseria meningitidis O-acetyltransferase polypeptide; immunogenic compositions; vaccine for generating a protective immune response to Neisseria meningitidis |
| 04/06/2006 | US20060073164 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/06/2006 | US20060073161 Nucleic acid and amino acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073146 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 04/06/2006 | US20060073145 Methods and compositions for inhibiting CD14 mediated cell activation |
| 04/06/2006 | US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073125 Isolation and use of solid tumor stem cells |
| 04/06/2006 | US20060073123 Adenovirus vectors for immunotherapy |
| 04/06/2006 | US20060073120 IKKalpha and IKKbeta specific inhibitors |
| 04/06/2006 | US20060073119 Methods for treating neurodegenerative disorders |
| 04/06/2006 | US20060073115 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis, inflamamatory disorders or infection by microorganisms |
| 04/06/2006 | DE102004047391A1 Device useful to provide material e.g. medicine in first biological cells (target cells), comprising a first chamber to provide second biological cells, second chamber to provide particles and third chamber to mix second cells and particles |
| 04/06/2006 | DE102004047269A1 New protein or peptide involved in biosynthesis of lysolipins, useful for preparing lysolipin antibiotics in transformed cells |
| 04/06/2006 | DE102004046616A1 Active pharmaceutical ingredient for the treatment of hospital acquired infection with selected nucleic acid sequence |
| 04/06/2006 | DE102004046116A1 Pullulanasen aus psychrophilen Organismen Pullulanases from psychrophilic organisms |
| 04/06/2006 | CA2848573A1 Rnai modulation of apob and uses thereof |
| 04/06/2006 | CA2824308A1 Targeting opposite strand replication intermediates of single-stranded viruses by rnai |
| 04/06/2006 | CA2623830A1 Hematological cancer profiling system |
| 04/06/2006 | CA2582940A1 Myostatin isoform |
| 04/06/2006 | CA2582814A1 Single-stranded antimicrobial oligonucleotides and uses thereof |
| 04/06/2006 | CA2582051A1 Collagen producing plants and methods of generating and using same |
| 04/06/2006 | CA2582041A1 Recombinant human t2 rnase and uses thereof |
| 04/06/2006 | CA2581969A1 Telomelysin-gfp gene-containing recombinant virus |
| 04/06/2006 | CA2581840A1 Optimized vaccines to provide protection against ebola and other viruses |
| 04/06/2006 | CA2581487A1 Isocyclomaltooligosaccharide (s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses |
| 04/06/2006 | CA2581468A1 Promoter, promoter control elements, and combinations, and uses thereof |
| 04/06/2006 | CA2581452A1 Promoter molecules for use in plants |
| 04/06/2006 | CA2581224A1 Targeting opposite strand replication intermediates of single-stranded viruses by rnai |
| 04/06/2006 | CA2580996A1 Method of treating an inflammatory disease by double stranded ribonucleic acid |
| 04/06/2006 | CA2580940A1 Maize with modified cinnamoyl coa reductase enzyme having reduced lignin and improved digestibility |
| 04/06/2006 | CA2579971A1 A bacterial atp synthase binding domain |
| 04/06/2006 | CA2554718A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/05/2006 | EP1643249A1 Bio-chip |
| 04/05/2006 | EP1643248A1 Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method |
| 04/05/2006 | EP1642987A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 04/05/2006 | EP1642982A1 Recombinant dna viruses comprising a dna that is complementary to an rna virus replicon, and applications thereof |
| 04/05/2006 | EP1642981A1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |
| 04/05/2006 | EP1642980A1 Modified proteins and methods of their production |
| 04/05/2006 | EP1642979A1 Fucosyltransferase gene |
| 04/05/2006 | EP1642978A1 Method of detecting sars coronavirus |
| 04/05/2006 | EP1642977A1 Gene participating in growth promoting function of acetic acid bacterium and utilization of the same |
| 04/05/2006 | EP1642976A1 Quantitative pcr detection method for plant of specified genus in food or food raw material |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642974A1 Recombinant soluble Fc receptors |